These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6669987)

  • 1. Hormonal therapy of gynecologic cancers.
    Durant JR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):29-33. PubMed ID: 6669987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
    Geisler HE
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptors in endolymphatic stromal myosis.
    Baker VV; Walton LA; Fowler WC; Currie JL
    Obstet Gynecol; 1984 Mar; 63(3 Suppl):72S-74S. PubMed ID: 6700885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of progestins in the treatment of breast cancer.
    Blumenschein GR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):7-10. PubMed ID: 6230722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal and systemic chemotherapy for advanced endometrial adenocarcinoma: a case report.
    Vaughn CB; Chapman JL; Herschman BR; Bonczak MJ; Treisman EJ; Groshko GA; Nirenberg PL
    Med Pediatr Oncol; 1990; 18(1):68-71. PubMed ID: 2294393
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer.
    Rose PG; Reale FR; Longcope C; Hunter RE
    Obstet Gynecol; 1990 Aug; 76(2):258-63. PubMed ID: 2371031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.
    Ettinger DS; Allegra J; Bertino JR; Bonomi P; Browder H; Byrne P; Carpenter J; Catalano R; Creech R; Dana B
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):9-14. PubMed ID: 3026052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    Gal D; Edman CD; Vellios F; Forney JP
    Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate therapy for advanced breast cancer.
    Gregory EJ; Cohen SC; Oines DW; Mims CH
    J Clin Oncol; 1985 Feb; 3(2):155-60. PubMed ID: 3838187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology.
    Bonte J; Janssens JP; Ide P
    Eur J Gynaecol Oncol; 1986; 7(1):45-50. PubMed ID: 2938955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
    Kauppila A
    Acta Obstet Gynecol Scand; 1984; 63(5):441-50. PubMed ID: 6238499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol acetate: first-line therapy for advanced breast cancer.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with hormonal therapy in advanced epithelial ovarian cancer.
    van der Vange N; Greggi S; Burger CW; Kenemans P; Vermorken JB
    Acta Oncol; 1995; 34(6):813-20. PubMed ID: 7576750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.